2024

1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

   Blood, Vol. 143, Núm. 18, pp. 1807-1815

2. Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 246-252

3. Colonoscopy Satisfaction and Safety Questionnaire based on patient experience (CSSQP): A valuable quality tool for all colonoscopies

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 1-13

4. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

   British Journal of Cancer, Vol. 130, Núm. 5, pp. 777-787

5. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry

   Gastric Cancer, Vol. 27, Núm. 1, pp. 131-145

6. Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy

   International Journal of Cancer, Vol. 154, Núm. 1, pp. 124-132

7. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

   IJID Regions, Vol. 10, pp. 146-149

8. IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management

   Digestive Diseases and Sciences, Vol. 69, Núm. 3, pp. 749-765

9. Influence of social support and stressful life events on adherence to colorectal cancer screening using faecal occult blood test in Spanish medium risk population

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 14-23

10. Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry

    Clinical and Translational Oncology

11. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU

    Revista espanola de enfermedades digestivas, Vol. 116, Núm. 2, pp. 83-113

12. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 401-432

13. Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology

    Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 98-108

14. Mycobacterium malmoense wrist septic arthritis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 221-223

15. Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

    European urology oncology, Vol. 7, Núm. 3, pp. 447-455

16. Prospective study of predictors for anxiety, depression, and somatization in a sample of 1807 cancer patients

    Scientific reports, Vol. 14, Núm. 1, pp. 3188

17. Quality indicators for the diagnosis and treatment of breast cancer integrated assistance: A critical appraisal (Pag. -e 102067)

    Semergen: revista española de medicina de familia, Núm. 1, pp. 6-6

18. Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 4, pp. 864-871

19. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

20. Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study

    Clinical and Translational Oncology